Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
PP2
i
Other names:
PP2, AG1879
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Pfizer, University of Michigan
Drug class:
Src kinase inhibitor
Related drugs:
‹
dasatinib (215)
bosutinib (46)
TPX-0022 (8)
AZD0530 (7)
BAL3833 (4)
NXP900 (3)
TPX-0046 (2)
AZD 0424 (0)
JNJ-26483327 (0)
tirbanibulin ointment (0)
XL228 (0)
KX2-391 oral (0)
dasatinib (215)
bosutinib (46)
TPX-0022 (8)
AZD0530 (7)
BAL3833 (4)
NXP900 (3)
TPX-0046 (2)
AZD 0424 (0)
JNJ-26483327 (0)
tirbanibulin ointment (0)
XL228 (0)
KX2-391 oral (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF mutation
Thyroid Gland Papillary Carcinoma
BRAF mutation
Thyroid Gland Papillary Carcinoma
PP2
Sensitive: D – Preclinical
PP2
Sensitive
:
D
PP2
Sensitive: D – Preclinical
PP2
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040 + PP2
Sensitive: D – Preclinical
CI-1040 + PP2
Sensitive
:
D
CI-1040 + PP2
Sensitive: D – Preclinical
CI-1040 + PP2
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login